Alphatec has been granted a patent for an automated electrophysiological response analysis apparatus that identifies and eliminates non-physiological artifact noise from averaged evoked potential signals. The apparatus includes stimulating and recording electrodes, along with a processor programmed to execute an evoked potential analysis algorithm. GlobalData’s report on Alphatec gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Alphatec Holdings Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Alphatec, Prosthetic cardiac valves was a key innovation area identified from patents. Alphatec's grant share as of May 2024 was 42%. Grant share is based on the ratio of number of grants to total number of patents.

Automated apparatus for analyzing and eliminating non-physiological noise

Source: United States Patent and Trademark Office (USPTO). Credit: Alphatec Holdings Inc

A recently granted patent (Publication Number: US11986321B2) discloses an innovative apparatus designed for the automated analysis of evoked potentials in patients. The apparatus includes stimulating electrodes to activate peripheral nerves, recording electrodes to capture electrophysiological responses, and a processor programmed with an automated evoked potential analysis algorithm. This algorithm is capable of monitoring, detecting, identifying, and eliminating non-physiological artifact noise in the nervous system's electrical waveforms generated in response to stimulation. By determining the presence of ambient electrical noise or artifact noise, the processor can classify and remove unwanted signals, generate averaged evoked potential signals, and provide positioning effect information about the patient.

Furthermore, the apparatus detailed in the patent includes features such as the identification of pacing artifact noise from pacemakers, the utilization of specific characteristics like slope and amplitude for noise detection, and the transmission of positioning effect information for display or alerts. The stimulating electrodes can be attached to the patient's arms and legs, while recording electrodes can be placed on various body parts like the head, neck, spine, arms, legs, and torso. The collection of signals used for generating averaged evoked potential signals excludes those containing non-physiological artifact noise, ensuring accurate and reliable analysis of the patient's electrophysiological responses. This patented technology represents a significant advancement in automated evoked potential analysis, offering enhanced precision and efficiency in clinical settings.

To know more about GlobalData’s detailed insights on Alphatec, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.